Literature DB >> 14316214

STUDIES OF THE UPTAKE OF TRITIUM LABELLED MEPACRINE BY TUMOURS.

J M YOUNG, F WILD, I SIMON-REUSS.   

Abstract

Entities:  

Keywords:  BLOOD; BONE MARROW; BRAIN; CARCINOMA 256, WALKER; EXPERIMENTAL LAB STUDY; INTESTINES; KIDNEY; LIVER; METABOLISM; MUSCLES; NEOPLASM RADIOTHERAPY; PHARMACOLOGY; QUINACRINE; RADIOAUTOGRAPHY; RATS; SPLEEN; TESTIS; TRITIUM

Mesh：

Substances：

Year:  1965        PMID： 14316214      PMCID： PMC2071367          DOI： 10.1038/bjc.1965.44

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  10 in total

1.  [Resorption & excretion of fluorescent substances].

Authors:  M WEISSBERG
Journal:  Z Krebsforsch       Date:  1959

2.  INVESTIGATION OF A RADIOACTIVE DRUG (TRA 119) WITH SPECIAL REFERENCE TO AUTORADIOGRAPHIC AND RELATED STUDIES.

Authors:  J S MITCHELL; E A KING; D H MARRIAN; B CHIPPERFIELD
Journal:  Acta Radiol Ther Phys Biol       Date:  1963-10

3.  LOCALIZATION OF AMINOACRIDINE FLUORESCENCE IN LUNG TUMORS OF RATS.

Authors:  N B ACKERMAN; A SHEMESH
Journal:  JAMA       Date:  1964-03-14       Impact factor: 56.272

4.  Quinacrine in the treatment of refractory petit-mal epilepsy.

Authors:  W A SIBLEY; H J TUCKER; C T RANDT
Journal:  N Engl J Med       Date:  1962-08-16       Impact factor: 91.245

5.  Studies on the administration of quinacrine to tumor-bearing mice.

Authors:  J W VASSEY; J EDMONDS; J L IRVIN; J A GREEN; E M IRVIN
Journal:  Cancer Res       Date:  1955-10       Impact factor: 12.701

6.  Distribution of mepacrine in the organs of different animal species, and in the components of liver cells.

Authors:  G A SNOW; E W HURST
Journal:  Br J Pharmacol Chemother       Date:  1956-06

7.  Spectrophotometric study of the excretion products of mepacrine compared with synthetic acridine and diphenylamine derivatives.

Authors:  E J King; M Gilchrist; A L Tárnoky
Journal:  Biochem J       Date:  1946       Impact factor: 3.857

8.  Laboratory and clinical studies of some quinol diphosphates and related compounds as chemical radiosensitizers and the development of a radioactive drug.

Authors:  D H MARRIAN; B MARSHALL; J S MITCHELL
Journal:  Chemotherapia (Basel)       Date:  1961

9.  The use of atabrine (quinacrine) in the control of recurrent neoplastic effusions. A preliminary report.

Authors:  A GELLHORN; J ZAIDENWEBER; J ULTMANN; E HIRSCHBERG
Journal:  Dis Chest       Date:  1961-02

10.  On the access of blood-borne dyes to various tumour regions.

Authors:  R J GOLDACRE; B SYLVEN
Journal:  Br J Cancer       Date:  1962-06       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.